© 2021 MJH Life Sciences and HCPLive. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.
December 18, 2020
Novartis indicates they will address manufacturing issues cited by the FDA.
December 09, 2020
Dr. Giorgino discusses how combining SGLT2 Inhibitors and GLP-1RA could be combined for treating type 2 diabetes.
December 04, 2020
Diabetic patients are more susceptible to severe COVID-19 outcomes.
July 20, 2020
A secondary ACCELERATE assessment shows a particular set of patients who may benefit from Lp(a)-lowering novel agents.
July 15, 2020
The practice of genetic testing has been useful in clinically addressing found cases of familial hypercholesterolemia, among other conditions, but no clinical practice guidelines currently exist for testing patients with suspected hereditary dyslipidemia.
June 23, 2020
While often referred to as "Good cholesterol" new research suggests HDL measurements do little for predicting risk of heart attack in Black patients
June 17, 2020
Discussing how advances in care and therapeutic agents have impacted the management of diabetes in 2020.
June 13, 2020
Deepak Bhatt, MD, MPH, discusses the results of the latest REDUCE-IT analysis, titled REDUCE-IT DIABETES, presented at ADA 2020.
June 09, 2020
A new study from the University of Arizona is shedding light on the psychological impact of Tai Chi in patients with cardiovascular disease.
June 08, 2020
A new analysis examines impact of treatment adherence in more than 1.2 million patients.